ArticleCancer immunology, immunotherapy : CII2026
Effectiveness of ICI-ICI versus ICI-TKI combinations in patients with IMDC intermediate- and poor-risk metastatic renal cell carcinoma: a sub-analysis of the MEET-URO 33 study.
Michele Maffezzoli et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.